 | • レポートコード：GIR-202A2479 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、結合型ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。結合型ワクチンの種類別市場規模（Hibワクチン、髄膜炎菌ワクチン、肺炎球菌ワクチン、その他）、用途別市場規模（子供、大人）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・結合型ワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、GSK、Sanofi、Merck、Walvax Biotechnology、Royal (Wuxi) Bio-Pharmaceutical、Bharat Biotech、Zhifei Biologic ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：Hibワクチン、髄膜炎菌ワクチン、肺炎球菌ワクチン、その他 ・用途別分析2016年-2026年：子供、大人 ・結合型ワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・結合型ワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・結合型ワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・結合型ワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・結合型ワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Conjugate Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Conjugate Vaccine size is estimated to be XX million in 2021 from USD 9960.9 million in 2020, with a change of XX% between 2020 and 2021. The global Conjugate Vaccine market size is expected to grow at a CAGR of 3.1% for the next five years.
Market segmentation
Conjugate Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Hib Vaccine
Meningococcal Vaccine
Pneumococcal Vaccine
Others
Market segment by Application can be divided into
Children
Adult
The key market players for global Conjugate Vaccine market are listed below:
Pfizer
GSK
Sanofi
Merck
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Bharat Biotech
Zhifei Biologic
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Conjugate Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Conjugate Vaccine, with price, sales, revenue and global market share of Conjugate Vaccine from 2019 to 2021.
Chapter 3, the Conjugate Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Conjugate Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Conjugate Vaccine market forecast, by regions, type and end users, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Conjugate Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Conjugate Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Conjugate Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Hib Vaccine
1.2.3 Meningococcal Vaccine
1.2.4 Pneumococcal Vaccine
1.2.5 Others
1.3 Market Analysis by End Users
1.3.1 Overview: Global Conjugate Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Children
1.3.3 Adult
1.4 Global Conjugate Vaccine Market Size & Forecast
1.4.1 Global Conjugate Vaccine Sales in Value (2016-2026))
1.4.2 Global Conjugate Vaccine Sales in Volume (2016-2026)
1.4.3 Global Conjugate Vaccine Price by Type (2016-2026) & (USD/Unit)
1.5 Global Conjugate Vaccine Production Capacity Analysis
1.5.1 Global Conjugate Vaccine Total Production Capacity (2016-2026)
1.5.2 Global Conjugate Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Conjugate Vaccine Market Drivers
1.6.2 Conjugate Vaccine Market Restraints
1.6.3 Conjugate Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Conjugate Vaccine Product and Services
2.1.4 Pfizer Conjugate Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Conjugate Vaccine Product and Services
2.2.4 GSK Conjugate Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Conjugate Vaccine Product and Services
2.3.4 Sanofi Conjugate Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Conjugate Vaccine Product and Services
2.4.4 Merck Conjugate Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Walvax Biotechnology
2.5.1 Walvax Biotechnology Details
2.5.2 Walvax Biotechnology Major Business
2.5.3 Walvax Biotechnology Conjugate Vaccine Product and Services
2.5.4 Walvax Biotechnology Conjugate Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Royal (Wuxi) Bio-Pharmaceutical
2.6.1 Royal (Wuxi) Bio-Pharmaceutical Details
2.6.2 Royal (Wuxi) Bio-Pharmaceutical Major Business
2.6.3 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Product and Services
2.6.4 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Bharat Biotech
2.7.1 Bharat Biotech Details
2.7.2 Bharat Biotech Major Business
2.7.3 Bharat Biotech Conjugate Vaccine Product and Services
2.7.4 Bharat Biotech Conjugate Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Zhifei Biologic
2.8.1 Zhifei Biologic Details
2.8.2 Zhifei Biologic Major Business
2.8.3 Zhifei Biologic Conjugate Vaccine Product and Services
2.8.4 Zhifei Biologic Conjugate Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Conjugate Vaccine Sales by Manufacturer
3.1 Global Conjugate Vaccine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Conjugate Vaccine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Conjugate Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Conjugate Vaccine Manufacturer Market Share
3.4.2 Top 6 Conjugate Vaccine Manufacturer Market Share
3.5 Global Conjugate Vaccine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Conjugate Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Conjugate Vaccine Market Size by Region
4.1.1 Global Conjugate Vaccine Sales in Volume by Region (2016-2026)
4.1.2 Global Conjugate Vaccine Revenue by Region (2016-2026)
4.2 North America Conjugate Vaccine Revenue (2016-2026)
4.3 Europe Conjugate Vaccine Revenue (2016-2026)
4.4 Asia-Pacific Conjugate Vaccine Revenue (2016-2026)
4.5 South America Conjugate Vaccine Revenue (2016-2026)
4.6 Middle East and Africa Conjugate Vaccine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Conjugate Vaccine Sales in Volume by Type (2016-2026)
5.2 Global Conjugate Vaccine Revenue by Type (2016-2026)
5.3 Global Conjugate Vaccine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Conjugate Vaccine Sales in Volume by Application (2016-2026)
6.2 Global Conjugate Vaccine Revenue by Application (2016-2026)
6.3 Global Conjugate Vaccine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Conjugate Vaccine Sales by Type (2016-2026)
7.2 North America Conjugate Vaccine Sales by Application (2016-2026)
7.3 North America Conjugate Vaccine Market Size by Country
7.3.1 North America Conjugate Vaccine Sales in Volume by Country (2016-2026)
7.3.2 North America Conjugate Vaccine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Conjugate Vaccine Sales by Type (2016-2026)
8.2 Europe Conjugate Vaccine Sales by Application (2016-2026)
8.3 Europe Conjugate Vaccine Market Size by Country
8.3.1 Europe Conjugate Vaccine Sales in Volume by Country (2016-2026)
8.3.2 Europe Conjugate Vaccine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Conjugate Vaccine Sales by Type (2016-2026)
9.2 Asia-Pacific Conjugate Vaccine Sales by Application (2016-2026)
9.3 Asia-Pacific Conjugate Vaccine Market Size by Region
9.3.1 Asia-Pacific Conjugate Vaccine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Conjugate Vaccine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Conjugate Vaccine Sales by Type (2016-2026)
10.2 South America Conjugate Vaccine Sales by Application (2016-2026)
10.3 South America Conjugate Vaccine Market Size by Country
10.3.1 South America Conjugate Vaccine Sales in Volume by Country (2016-2026)
10.3.2 South America Conjugate Vaccine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Conjugate Vaccine Sales by Type (2016-2026)
11.2 Middle East & Africa Conjugate Vaccine Sales by Application (2016-2026)
11.3 Middle East & Africa Conjugate Vaccine Market Size by Country
11.3.1 Middle East & Africa Conjugate Vaccine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Conjugate Vaccine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Conjugate Vaccine Typical Distributors
12.3 Conjugate Vaccine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Conjugate Vaccine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Conjugate Vaccine Revenue by Application, (USD Million), 2021-2026
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Conjugate Vaccine Product and Services
Table 6. Pfizer Conjugate Vaccine Sales (Million Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Major Business
Table 9. GSK Conjugate Vaccine Product and Services
Table 10. GSK Conjugate Vaccine Sales (Million Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Sanofi Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi Major Business
Table 13. Sanofi Conjugate Vaccine Product and Services
Table 14. Sanofi Conjugate Vaccine Sales (Million Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Merck Basic Information, Manufacturing Base and Competitors
Table 16. Merck Major Business
Table 17. Merck Conjugate Vaccine Product and Services
Table 18. Merck Conjugate Vaccine Sales (Million Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 20. Walvax Biotechnology Major Business
Table 21. Walvax Biotechnology Conjugate Vaccine Product and Services
Table 22. Walvax Biotechnology Conjugate Vaccine Sales (Million Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Royal (Wuxi) Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Royal (Wuxi) Bio-Pharmaceutical Major Business
Table 25. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Product and Services
Table 26. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales (Million Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 28. Bharat Biotech Major Business
Table 29. Bharat Biotech Conjugate Vaccine Product and Services
Table 30. Bharat Biotech Conjugate Vaccine Sales (Million Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Zhifei Biologic Basic Information, Manufacturing Base and Competitors
Table 32. Zhifei Biologic Major Business
Table 33. Zhifei Biologic Conjugate Vaccine Product and Services
Table 34. Zhifei Biologic Conjugate Vaccine Sales (Million Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Conjugate Vaccine Sales by Manufacturer (2019-2021e) & (Million Unit)
Table 36. Global Conjugate Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Conjugate Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Conjugate Vaccine Production Capacity by Company, (Million Unit): 2020 VS 2021
Table 39. Head Office and Conjugate Vaccine Production Site of Key Manufacturer
Table 40. Conjugate Vaccine New Entrant and Capacity Expansion Plans
Table 41. Conjugate Vaccine Mergers & Acquisitions in the Past Five Years
Table 42. Global Conjugate Vaccine Sales by Region (2016-2021e) & (Million Unit)
Table 43. Global Conjugate Vaccine Sales by Region (2021-2026) & (Million Unit)
Table 44. Global Conjugate Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 45. Global Conjugate Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 46. Global Conjugate Vaccine Sales by Type (2016-2021e) & (Million Unit)
Table 47. Global Conjugate Vaccine Sales by Type (2021-2026) & (Million Unit)
Table 48. Global Conjugate Vaccine Revenue by Type (2016-2021e) & (USD Million)
Table 49. Global Conjugate Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 50. Global Conjugate Vaccine Price by Type (2016-2021e) & (USD/Unit)
Table 51. Global Conjugate Vaccine Price by Type (2021-2026) & (USD/Unit)
Table 52. Global Conjugate Vaccine Sales by Application (2016-2021e) & (Million Unit)
Table 53. Global Conjugate Vaccine Sales by Application (2021-2026) & (Million Unit)
Table 54. Global Conjugate Vaccine Revenue by Application (2016-2021e) & (USD Million)
Table 55. Global Conjugate Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 56. Global Conjugate Vaccine Price by Application (2016-2021e) & (USD/Unit)
Table 57. Global Conjugate Vaccine Price by Application (2021-2026) & (USD/Unit)
Table 58. North America Conjugate Vaccine Sales by Country (2016-2021e) & (Million Unit)
Table 59. North America Conjugate Vaccine Sales by Country (2021-2026) & (Million Unit)
Table 60. North America Conjugate Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 61. North America Conjugate Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 62. North America Conjugate Vaccine Sales by Type (2016-2021e) & (Million Unit)
Table 63. North America Conjugate Vaccine Sales by Type (2021-2026) & (Million Unit)
Table 64. North America Conjugate Vaccine Sales by Application (2016-2021e) & (Million Unit)
Table 65. North America Conjugate Vaccine Sales by Application (2021-2026) & (Million Unit)
Table 66. Europe Conjugate Vaccine Sales by Country (2016-2021e) & (Million Unit)
Table 67. Europe Conjugate Vaccine Sales by Country (2021-2026) & (Million Unit)
Table 68. Europe Conjugate Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 69. Europe Conjugate Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 70. Europe Conjugate Vaccine Sales by Type (2016-2021e) & (Million Unit)
Table 71. Europe Conjugate Vaccine Sales by Type (2021-2026) & (Million Unit)
Table 72. Europe Conjugate Vaccine Sales by Application (2016-2021e) & (Million Unit)
Table 73. Europe Conjugate Vaccine Sales by Application (2021-2026) & (Million Unit)
Table 74. Asia-Pacific Conjugate Vaccine Sales by Region (2016-2021e) & (Million Unit)
Table 75. Asia-Pacific Conjugate Vaccine Sales by Region (2021-2026) & (Million Unit)
Table 76. Asia-Pacific Conjugate Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 77. Asia-Pacific Conjugate Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 78. Asia-Pacific Conjugate Vaccine Sales by Type (2016-2021e) & (Million Unit)
Table 79. Asia-Pacific Conjugate Vaccine Sales by Type (2021-2026) & (Million Unit)
Table 80. Asia-Pacific Conjugate Vaccine Sales by Application (2016-2021e) & (Million Unit)
Table 81. Asia-Pacific Conjugate Vaccine Sales by Application (2021-2026) & (Million Unit)
Table 82. South America Conjugate Vaccine Sales by Country (2016-2021e) & (Million Unit)
Table 83. South America Conjugate Vaccine Sales by Country (2021-2026) & (Million Unit)
Table 84. South America Conjugate Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 85. South America Conjugate Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 86. South America Conjugate Vaccine Sales by Type (2016-2021e) & (Million Unit)
Table 87. South America Conjugate Vaccine Sales by Type (2021-2026) & (Million Unit)
Table 88. South America Conjugate Vaccine Sales by Application (2016-2021e) & (Million Unit)
Table 89. South America Conjugate Vaccine Sales by Application (2021-2026) & (Million Unit)
Table 90. Middle East & Africa Conjugate Vaccine Sales by Country (2016-2021e) & (Million Unit)
Table 91. Middle East & Africa Conjugate Vaccine Sales by Country (2021-2026) & (Million Unit)
Table 92. Middle East & Africa Conjugate Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 93. Middle East & Africa Conjugate Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 94. Middle East & Africa Conjugate Vaccine Sales by Type (2016-2021e) & (Million Unit)
Table 95. Middle East & Africa Conjugate Vaccine Sales by Type (2021-2026) & (Million Unit)
Table 96. Middle East & Africa Conjugate Vaccine Sales by Application (2016-2021e) & (Million Unit)
Table 97. Middle East & Africa Conjugate Vaccine Sales by Application (2021-2026) & (Million Unit)
Table 98. Direct Channel Pros & Cons
Table 99. Indirect Channel Pros & Cons
Table 100. Conjugate Vaccine Typical Distributors
Table 101. Conjugate Vaccine Typical Customers
List of Figures
Figure 1. Conjugate Vaccine Picture
Figure 2. Global Conjugate Vaccine Sales Market Share by Type in 2020
Figure 3. Hib Vaccine
Figure 4. Meningococcal Vaccine
Figure 5. Pneumococcal Vaccine
Figure 6. Others
Figure 7. Global Conjugate Vaccine Sales Market Share by Application in 2020
Figure 8. Children
Figure 9. Adult
Figure 10. Global Conjugate Vaccine Market Size, (USD Million) & (Million Unit): 2020 VS 2021 VS 2026
Figure 11. Global Conjugate Vaccine Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. Global Conjugate Vaccine Sales (2016-2026) & (Million Unit)
Figure 13. Global Conjugate Vaccine Price by Type (2016-2026) & (USD/Unit)
Figure 14. Global Conjugate Vaccine Production Capacity (2016-2026) & (Million Unit)
Figure 15. Global Conjugate Vaccine Production Capacity by Geographic Region: 2020 VS 2021
Figure 16. Conjugate Vaccine Market Drivers
Figure 17. Conjugate Vaccine Market Restraints
Figure 18. Conjugate Vaccine Market Trends
Figure 19. Global Conjugate Vaccine Sales Market Share by Manufacturer in 2020
Figure 20. Global Conjugate Vaccine Revenue Market Share by Manufacturer in 2020
Figure 21. Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 22. Top 3 Conjugate Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 23. Top 6 Conjugate Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 24. Global Conjugate Vaccine Sales Market Share by Region (2016-2026)
Figure 25. Global Conjugate Vaccine Revenue Market Share by Region (2016-2026)
Figure 26. North America Conjugate Vaccine Revenue (2016-2026) & (USD Million)
Figure 27. Europe Conjugate Vaccine Revenue (2016-2026) & (USD Million)
Figure 28. Asia-Pacific Conjugate Vaccine Revenue (2016-2026) & (USD Million)
Figure 29. South America Conjugate Vaccine Revenue (2016-2026) & (USD Million)
Figure 30. Middle East & Africa Conjugate Vaccine Revenue (2016-2026) & (USD Million)
Figure 31. Global Conjugate Vaccine Sales Market Share by Type (2016-2026)
Figure 32. Global Conjugate Vaccine Revenue Market Share by Type (2016-2026)
Figure 33. Global Conjugate Vaccine Price by Type (2016-2026) & (USD/Unit)
Figure 34. Global Conjugate Vaccine Sales Market Share by Application (2016-2026)
Figure 35. Global Conjugate Vaccine Revenue Market Share by Application (2016-2026)
Figure 36. Global Conjugate Vaccine Price by Application (2016-2026) & (USD/Unit)
Figure 37. North America Conjugate Vaccine Sales Market Share by Type (2016-2026)
Figure 38. North America Conjugate Vaccine Sales Market Share by Application (2016-2026)
Figure 39. North America Conjugate Vaccine Sales Market Share by Country (2016-2026)
Figure 40. North America Conjugate Vaccine Revenue Market Share by Country (2016-2026)
Figure 41. United States Conjugate Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Conjugate Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Conjugate Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Conjugate Vaccine Sales Market Share by Type (2016-2026)
Figure 45. Europe Conjugate Vaccine Sales Market Share by Application (2016-2026)
Figure 46. Europe Conjugate Vaccine Sales Market Share by Country (2016-2026)
Figure 47. Europe Conjugate Vaccine Revenue Market Share by Country (2016-2026)
Figure 48. Germany Conjugate Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Conjugate Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Conjugate Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Conjugate Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Conjugate Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Conjugate Vaccine Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Conjugate Vaccine Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Conjugate Vaccine Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Conjugate Vaccine Revenue Market Share by Region (2016-2026)
Figure 57. China Conjugate Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Conjugate Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Korea Conjugate Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Conjugate Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Conjugate Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Conjugate Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Conjugate Vaccine Sales Market Share by Type (2016-2026)
Figure 64. South America Conjugate Vaccine Sales Market Share by Application (2016-2026)
Figure 65. South America Conjugate Vaccine Sales Market Share by Country (2016-2026)
Figure 66. South America Conjugate Vaccine Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Conjugate Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Conjugate Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East & Africa Conjugate Vaccine Sales Market Share by Type (2016-2026)
Figure 70. Middle East & Africa Conjugate Vaccine Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Conjugate Vaccine Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Conjugate Vaccine Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Conjugate Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Egypt Conjugate Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Conjugate Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. South Africa Conjugate Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
世界の23価肺炎球菌多糖類ワクチン市場 2021：企業別、地域別、種類・用途別 The 23-Valent Pneumococcal Polysaccharide Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…- 世界の複合紡糸口金市場 2021：企業別、地域別、種類・用途別 The Conjugate Spinneret market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 世界の炭疽菌ワクチン市場 2021：企業別、地域別、種類・用途別 The Anthrax Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…
- 世界のアミノ酸培地市場 2021：企業別、地域別、種類・用途別 The Amino Acid Culture Media market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界の子供用芸術品・工芸品市場 2021：企業別、地域別、種類・用途別 The Arts and Crafts for Children market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…